Cited by 69Phytoestrogen effects and researchNutritional Studies and DietCancer Risks and Factors

Effect of dietary soy intake on breast cancer risk according to menopause and hormone receptor status

Cho, Y A, Kim, J, Park, K-S, Lim, S-Y, Shin, A, Sung, M-K, Ro, J·2010·European Journal of Clinical Nutrition

Abstract

Background Although high soy consumption may be associated with lower breast cancer risk in Asian populations, findings from epidemiological studies have been inconsistent. Objective We investigated the effects of soy intake on breast cancer risk among Korean women according to their menopausal and hormone receptor status. Methods We conducted a case-control study with 358 incident breast cancer patients and 360 age-matched controls with no history of malignant neoplasm. Dietary consumption of soy products was examined using a 103-item food frequency questionnaire. Results The estimated mean intakes of total soy and isoflavones from this study population were 76.5 g per day and 15.0 mg per day, respectively. Using a multivariate logistic regression model, we found a significant inverse association between soy intake and breast cancer risk, with a dose-response relationship (odds ratios (OR) (95% confidence interval (CI)) for the highest vs the lowest intake quartile: 0.36 (0.20-0.64)). When the data were stratified by menopausal status, the protective effect was observed only among postmenopausal women (OR (95% CI) for the highest vs the lowest intake quartile: 0.08 (0.03-0.22)). The association between soy and breast cancer risk did not differ according to estrogen receptor (ER)/progesterone receptor (PR) status, but the estimated intake of soy isoflavones showed an inverse association only among postmenopausal women with ER+/PR+ tumors. Conclusions Our findings suggest that…

Integrity signals

Registry

Crossref · 10.1038/ejcn.2010.95

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Of 44 case-control studies, 32 showed higher consumption of soy foods and/or soy isoflavones was associated with lower risk for primary breast cancer, breast cancer mortality, or improved markers of prognosis among the overall study population.

    “Overall, of the 44 case control studies, 32 showed that higher consumption of soy foods and/ or soy isoflavones was associated with lower risk for primary breast cancer [42-46,49-51,53,54,56-58,61-64,66,71-73,75,77-79,81,83], breast cancer mortality [55], or improved markers of prognosis (ER+ status vs receptor negative status) [74,82] among the overall study population.”
  • Eight of 12 (67%) studies examining high soy food or protein and six of seven (86%) studies examining high soy isoflavones reported inverse associations between soy and breast cancer risk.

    “Eight of 12 (67%) studies examining high soy food or protein [45,46,61,64,72,77,78,81] and six of seven (86%) studies examining high soy isoflavones [42,43,45,75,77,81] reported inverse associations between soy and breast cancer risk.”
  • Among case-control studies reporting odds ratios with confidence intervals, 11 of 19 (58%) showed significant inverse relationships between soy food or protein intake and breast cancer risk.

    “Of the 19 studies, 11 (58%) showed significant inverse relationships between soy food or protein intake and risk of breast cancer [44-46,61,64,71-73,77,78,81].”
  • Soy consumption may protect against the development of breast cancer, and less so against breast cancer recurrence and mortality, although this is based on observational data only.

    “Our review suggests that on the contrary, soy consumption may protect against the development of breast cancer [46,75,109,117], and less so, breast cancer recurrence and mortality [106,112], although this is based on observational data only.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cho, Y. A., Kim, J., Park, K.-S., Lim, S.-Y., Shin, A., Sung, M.-K., & Ro, J.
Affiliations
National Cancer Center (KR)
Corresponding author
Kim, J
Venue
European Journal of Clinical Nutrition
Published
2010-06-23
Volume
64
Issue
9
Pages
924-932
ISSN
  • 0954-3007 (ISSN-L)
  • 1476-5640
OpenAlex
W2051143424
Cited by
69
References
1
Citations by year
2025: 2 · 2024: 2 · 2023: 5 · 2022: 2 · 2021: 1 · 2020: 7 · 2019: 4 · 2018: 1 · 2017: 5 · 2016: 2 · 2015: 6 · 2014: 8 · 2013: 7 · 2012: 10
FWCI
5.20
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Phytoestrogen effects and research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Keywords
soy consumption, breast cancer risk, isoflavones, menopausal status, postmenopausal women, hormone receptor status, estrogen receptor, progesterone receptor, Korean women, dietary factors
MeSH terms
Adult, Aged, Breast Neoplasms, Diet Surveys, Dose-Response Relationship, Drug, Female, Humans, Isoflavones, Korea, Menopause, Middle Aged, Surveys and Questionnaires, Receptors, Estrogen, Receptors, Progesterone, Risk Factors, Incidence, Multivariate Analysis, Confidence Intervals, Logistic Models, Odds Ratio, Case-Control Studies, Soy Foods

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review